HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$2.29
-0.03 (-1.29%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+734.9% upside
Low Target
$13.94
Average Target
$19.12
High Target
$23.15
Current Price
$2.29
Current
$2.29
$2.29
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Scenario Analysis
Bear Case
$13.94
508.7%
Low target
Base Case
$19.12
+734.9%
Avg target
Bull Case
$23.15
+910.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$19.12
-93.7% vs high
Next Earnings Report
Apr 2, 2026 · After Market Close
6d
until earnings
EPS Est: $-0.35
Earnings in 6 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |